🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

300 mg Serving Size
833 Servings
Botanical Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

📊 Market median: 380.0mg (120 products) 📚 8 studies — no high-quality reviews
This product: 300mg

Other Ingredients

Maltodextrin

Label Claims — Verification

All Other
Structure/Function
All Other (99% of products) Structure/Function (67% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free Dairy Free

Product Information

📋 Directions for Use

Suggested use: As a dietary supplement, take 300 mg (about 1/8 tsp) once daily, or as directed by a physician.

⚠️ Warnings & Precautions

Always consult a physician before taking any dietary supplement.

Keep out of reach of children.

🧪 Formulation Notes

Feverfew Extract 300 mg per serving

Color may vary

Free of: Added sugar, soy, dairy, yeast, gluten

Additional Information

Use an accurate milligram scale. New

Contents are sold by weight, not volume. Settling may occur. Store in a dry, cool place.

Product Details

UPC / SKU X001QVBN8V
DSLD Entry Date 2025-04-24
Product Type Botanical
Form Powder
DSLD ID 330919
Data Updated 2026-04-11

Research Evidence

10 Research Sources
48 Avg Quality Score
4 Systematic Review
4 Rct
1 Meta Analysis
1 Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985
View all evidence for Feverfew →

Compare Similar Products

View all Feverfew products →